PTI-609: A Novel Analgesic that Binds Filamin A to Control Opioid Signaling

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|5|3|210-220

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.5, Iss.3, 2010-11, pp. : 210-220

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Opioid analgesic prescribing in Australia: a focus on gender and age

By  

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 24, Iss. 6, 2015-06 ,pp. : 628-636

John Wiley & Sons Inc

Access to resources Recommend Favorite

Individualizing analgesic prescription Part I: pharmacogenetics of opioid analgesics

By Samer Caroline Flora   Desmeules Jules Alexandre   Dayer Pierre  

Personalized Medicine, Vol. 3, Iss. 3, 2006-08 ,pp. : 239-269

Future Medicine

Access to resources Recommend Favorite

Longitudinal Analysis of Opioid Analgesic Dose and Diabetes Quality of Care Measures

By  

PAIN MEDICINE, Vol. 16, Iss. 11, 2015-11 ,pp. : 2134-2141

John Wiley & Sons Inc

Access to resources Recommend Favorite

National cohort study of opioid analgesic dose and risk of future hospitalization

By  

JOURNAL OF HOSPITAL MEDICINE, Vol. 10, Iss. 7, 2015-07 ,pp. : 425-431

John Wiley & Sons Inc

Access to resources Recommend Favorite

Opioid‐Induced Central Immune Signaling: Implications for Opioid Analgesia

By  

HEADACHE, Vol. 55, Iss. 4, 2015-04 ,pp. : 475-489

John Wiley & Sons Inc

Access to resources Recommend Favorite